HURRICANE CAPITAL ADVISORS LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.43M	Buy	+16,042	New	+$1.19M	0.56%	32

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's XBI Position: Q4 2023 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q4 2023: 16,042 shares worth $1.43M. The stake represents 0.56% of the portfolio and ranks #32 among its holdings.

746 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

HURRICANE CAPITAL ADVISORS LLC held 16,042 shares of State Street SPDR S&P Biotech ETF worth $1.43M as of Q4 2023.
State Street SPDR S&P Biotech ETF was a new HURRICANE CAPITAL ADVISORS LLC position in Q4 2023.
State Street SPDR S&P Biotech ETF made up 0.56% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q4 2023, its #32 holding.
746 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q4 2023, filed 2 Nov 2026.